New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Matinas BioPharma Holdings, Inc.
MTNB
Shape
US Flag

AMEX

Unprofitable

Unprofitable

15M

Biotechnology

Next Earning date - 06 Nov 2024

15M

Biotechnology

Next Earning date - 06 Nov 2024

2.95USD
Shape-0.12 ( -3.91%)
favorite-chart

Relative Strenght

1
favorite-chart

Volume Buzz

113%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

93%

Quote Panel

Shape
Updated October 4, 2024
1W -16.67 % 1M -18.96 % 3M -64.67 % 1Y -58.45 %

Key Metrics

Shape
  • Market Cap

    14.80M


  • Shares Outstanding

    5.02M


  • Share in Float

    4.89M


  • Dividende

    0


  • Earning Date

    06 Nov 2024


  • Price Target

    2.95


  • Average Volume

    36573


  • Beta

    1.643


  • Range

    2.95-44.5


  • Industry

    Biotechnology


  • Website

    https://www.matinasbiopharma.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

Nanx

P/S Ratio

38.51x

P/B Ratio

0.2

Debt/Equity

2090.5%

Net Margin

$-5.5

EPS

How MTNB compares to sector?

P/E Ratio

Relative Strength

Shape

MTNB

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$64M

ShapeNaN%

2025-Revenue

$5.25

Shape-22826%

2025-EPS

$64M

Shape-1042%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.03
vs -0.03

Q4.22

arrow
arrow

N/A

-0.02
vs -0.03

Q1.23

arrow
arrow

N/A

-0.03
vs -0.03

Q2.23

arrow
arrow

N/A

-0.03
vs -0.03

Q3.23

arrow
arrow

N/A

-0.03
vs -0.03

Q4.23

arrow
arrow

N/A

-0.03
vs -0.02

Q1.24

arrow
arrow

N/A

-0.03
vs -0.03

Q2.24

arrow
arrow

N/A

-1.00
vs -0.03

Q3.24

arrow
arrow

N/A

-1.00
vs -0.03

Q4.24

arrow
arrow

N/A

-1.00
vs -0.03

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

-100%

NA  vs 33.3K

Q2.22

arrow
arrow

NA

1.1M  vs NA

Q3.22

arrow
arrow

NA

1.1M  vs NA

Q4.22

arrow
arrow

+3292%

1.1M  vs -33300

Q1.23

arrow
arrow

NA

1.1M  vs NA

Q2.23

arrow
arrow

-100%

NA  vs 1.1M

Q3.23

arrow
arrow

-100%

NA  vs 1.1M

Q4.23

arrow
arrow

-203%

-1096000.00  vs 1.1M

Q1.24

arrow
arrow

-100%

NA  vs 1.1M

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-14%

-0.14
vs -0.14

Q4.22

arrow
arrow

0%

-0.00
vs -0.14

Q1.23

arrow
arrow

-17%

-0.17
vs -0.00

Q2.23

arrow
arrow

-22%

-0.22
vs -0.17

Q3.23

arrow
arrow

-26%

-0.26
vs -0.22

Q4.23

arrow
arrow

-28%

-0.28
vs -0.26

Q1.24

arrow
arrow

-40%

-0.40
vs -0.28

Q2.24

arrow
arrow

-30%

-0.30
vs -0.40

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

51

51
vs 47

9%

Q4.22

arrow
arrow

56

56
vs 51

10%

Q1.23

arrow
arrow

50

50
vs 56

-11%

Q2.23

arrow
arrow

50

50
vs 50

NA

Q3.23

arrow
arrow

46

46
vs 50

-8%

Q4.23

arrow
arrow

51

51
vs 46

11%

Q1.24

arrow
arrow

42

42
vs 51

-18%

Q2.24

arrow
arrow

47

47
vs 42

12%

Earnings Growth

Latest News